The study reveals that in the exposure of the HeLa cell line to cannabinoids, TIMP-1 acts as a mediator, which upregulates the anti-cancer activity of cannabinoids within 12–24 h of inoculation (Ramer et al., 2007). Here, TIMP1 is linked to cancer.